Attention bioxcel therapeutics, inc. (btai) shareholders: kessler topaz meltzer & check, llp reminds shareholders of securities fraud class action lawsuit filed against bioxcel therapeutics, inc.

Radnor, pa. , july 12, 2023 /prnewswire/ -- the law firm of kessler topaz meltzer & check, llp (www.ktmc.com)  informs investors that a securities class action lawsuit has been filed in the united states district court for the district of connecticut against bioxcel therapeutics, inc. ("bioxcel") (nasdaq: btai).
BTAI Ratings Summary
BTAI Quant Ranking